GI Oncology
From the AGA Journals
Thermal ablation may reduce residual, recurrent adenomas
The U.S. Multi-Society Task Force currently recommends EMR-T for large nonpedunculated colorectal polyps, but real-world effectiveness remains...
Feature
CRC screening guidelines: 45 is the new 50, and 85 is the new 75
Multiple guidelines, levels of evidence, different screening methods with varying efficacy, individual risk factors - how can clinicians make...
Conference Coverage
Racial and ethnic minorities underrepresented in pancreatic cancer clinical trials
Better inclusion of underrepresented minorities in clinical trials is critical to reducing health care disparities and improving patient outcomes...
Conference Coverage
Pandemic colonoscopy restrictions may lead to worse CRC outcomes
"Recovery of the colonoscopy backlog is going to be a challenge that will take a while - maybe even years - to resolve," Dr. Jill Tinmouth...
From the Journals
USPSTF final recommendation on CRC screening: 45 is the new 50
“There are many tests available that can effectively screen for colorectal cancer and the right test is the one that gets done,” said Dr. Martha...
From the Journals
Does surgery for colorectal liver metastases release tumor cells?
Feature
First AI device for colonoscopy: Extra set of expert ‘eyes’
The GI Genius device, when combined with colonoscopy, enhances provider performance and reduces colon cancer risk by increasing adenoma detection...
News from the FDA/CDC
FDA approves frontline immunotherapy for gastric cancers
Nivolumab is now approved for the frontline treatment of advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal...
From the AGA Journals
Low-risk adenomas may not elevate risk of CRC-related death
The authors of the meta-analysis suggested that the screening interval for patients with LRAs be 10 years to match recommendations for patients...
Conference Coverage
Cumulative inflammatory burden predicts cancer risk in ulcerative colitis
Second study validates cumulative microscopic inflammation score as independent predictor of colorectal neoplasia.